Ten stocks in focus in Thursday morning trade
Indian markets are expected to trade in a range. Here is a list of ten stocks which are likely to be in focus today.
By ET Online | Updated:
NEW DELHI: Indian markets are expected to trade in a range on Thursday, tracking muted trend seen in other Asian markets and SGX Nifty.
After two days of sharp fall, the benchmarks took a pause on Wednesday and gained nearly half a percent in a range bound session.
"On Thursday, participants would be seen reacting to the FOMC outcome in early trade and that would set the tone for rest of the day as well," said Jayant Manglik, President-retail distribution, Religare Securities Limited.
"Broadly, we expect Nifty to decline further in coming sessions and consolidate around 7800 prior to any major directional move," he added.
Manglik is of the view that participants especially investors' should utilize this opportunity to accumulate fundamentally strong counters with medium to long term investment perspective."
Here is a list of ten stocks which are likely to be in focus today:
Ranbaxy Laboratories Ltd: Ranbaxy Laboratories today said the US Department of Justice has demanded information relating to the manner in which the company reports pricing data for certain products eligible for reimbursement under the Medicaid program.
Nucleus Software Ltd: The IT major announced a partnership with Japan's WASEDA University to rope in students for providing internship opportunities in its Noida campus.
Reliance Power Ltd: Reliance Power's Rs 12,300 crore deal to acquire hydroelectric assets of the Jaypee Group may take longer than expected as the seller has approached regulatory authorities for a tariff order that will rule out any ambiguity in the valuation of the transaction.
Reliance Industries Ltd: Mukesh Ambani-owned Reliance Jio Infocomm is on track to launch its full bouquet of fourth generation data and voice services by March 2015, given the increased pace and progress of its network rollouts, Credit Suisse said in a note to clients.
Apollo Tyres Ltd: Apollo Tyres today said it will start rolling out products from its 475 million Euro greenfield plant in Hungary by 2017.
Ipca Laboratories Ltd: Health Canada has asked Ipca Laboratories to voluntarily stop shipment of products to Canada, based on a review of recent manufacturing practices by the U.S. Food and Drug Administration, said media reports.
Natco Pharma & Orchid Chemicals: Natco Pharma and Orchid Chemicals and Pharmaceuticals have received an adverse observation report, commonly known as Form 483, after inspections conducted in their manufacturing units earlier this year by the US Food and Drug Administration, said media reports.
After two days of sharp fall, the benchmarks took a pause on Wednesday and gained nearly half a percent in a range bound session.
"On Thursday, participants would be seen reacting to the FOMC outcome in early trade and that would set the tone for rest of the day as well," said Jayant Manglik, President-retail distribution, Religare Securities Limited.
"Broadly, we expect Nifty to decline further in coming sessions and consolidate around 7800 prior to any major directional move," he added.
Manglik is of the view that participants especially investors' should utilize this opportunity to accumulate fundamentally strong counters with medium to long term investment perspective."
Here is a list of ten stocks which are likely to be in focus today:
ADVERTISEMENT
Ranbaxy Laboratories Ltd: Ranbaxy Laboratories today said the US Department of Justice has demanded information relating to the manner in which the company reports pricing data for certain products eligible for reimbursement under the Medicaid program.
Nucleus Software Ltd: The IT major announced a partnership with Japan's WASEDA University to rope in students for providing internship opportunities in its Noida campus.
Reliance Power Ltd: Reliance Power's Rs 12,300 crore deal to acquire hydroelectric assets of the Jaypee Group may take longer than expected as the seller has approached regulatory authorities for a tariff order that will rule out any ambiguity in the valuation of the transaction.
Reliance Industries Ltd: Mukesh Ambani-owned Reliance Jio Infocomm is on track to launch its full bouquet of fourth generation data and voice services by March 2015, given the increased pace and progress of its network rollouts, Credit Suisse said in a note to clients.
ADVERTISEMENT
MCX Ltd: Multi Commodity Exchange (MCX) has got a three-month conditional extension from the commodity markets regulator, Forward Markets Commission (FMC), to launch contracts till next March, said media reports. Apollo Tyres Ltd: Apollo Tyres today said it will start rolling out products from its 475 million Euro greenfield plant in Hungary by 2017.
ADVERTISEMENT
L&T Ltd: L&T Metro Rail Hyderabad Ltd, the developer of the 72-km elevated metro rail here, today said it has written a letter to the Telangana government and offered to walk out of the Rs 16,000 crore-plus project as a last resort if issues concerning it are not sorted out. Ipca Laboratories Ltd: Health Canada has asked Ipca Laboratories to voluntarily stop shipment of products to Canada, based on a review of recent manufacturing practices by the U.S. Food and Drug Administration, said media reports.
Natco Pharma & Orchid Chemicals: Natco Pharma and Orchid Chemicals and Pharmaceuticals have received an adverse observation report, commonly known as Form 483, after inspections conducted in their manufacturing units earlier this year by the US Food and Drug Administration, said media reports.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
